Mesoblast (MEOBF) Net Income (2014 - 2025)
Mesoblast's (MEOBF) quarterly Net Income came in at -$102.1 million in Q2 2025, down 16.13% year-over-year from -$121.8 million in Q2 2024, and down 16.13% quarter-over-quarter from -$88.0 million in Q2 2024.
Analysis
Mesoblast (MEOBF) Net Income (2014 - 2025) Analysis & Trends
Mesoblast has disclosed Net Income across 12 years of filings, most recently posting -$102.1 million for Q2 2025.
- In Q2 2025, Net Income fell 16.13% year-over-year to -$102.1 million; the TTM figure through Jun 2025 stood at -$253.4 million (down 99.9% YoY), while the FY2026 annual figure was -$57.5 million, up 43.71% from the prior year.
- Net Income came in at -$102.1 million for Q2 2025 at Mesoblast, down from -$88.0 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $178.7 million in Q2 2021 to a low of -$102.1 million in Q2 2025.
- Average Net Income over 5 years is -$7.6 million, with a median of -$19.2 million recorded in 2022.
- Year-over-year, Net Income jumped 201.57% in 2021 and sank 281.68% in 2023.
- Over 5 years, Net Income stood at $25.9 million in 2021, then fell by 5.62% to $24.5 million in 2022, then tumbled by 434.43% to -$81.9 million in 2023, then declined by 7.41% to -$88.0 million in 2024, then slipped by 16.13% to -$102.1 million in 2025.
- Per Business Quant data, the three most recent Net Income figures were -$102.1 million in Q2 2025, -$88.0 million in Q2 2024, and -$81.9 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 54.77 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -91.19 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -47.29 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 77.80 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -81.06 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -119.07 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 20.07 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -4.89 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 2.23 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -102.14 Mn |
| Jun 30, 2024 | -87.96 Mn |
| Jun 30, 2023 | -81.89 Mn |
| Mar 31, 2023 | 18.60 Mn |
| Dec 31, 2022 | 24.49 Mn |
| Sep 30, 2022 | -16.88 Mn |
| Jun 30, 2022 | -21.46 Mn |
| Mar 31, 2022 | 21.30 Mn |
| Dec 31, 2021 | 25.95 Mn |
| Sep 30, 2021 | -22.65 Mn |
| Jun 30, 2021 | 178.71 Mn |
| Mar 31, 2021 | -26.71 Mn |
| Dec 31, 2020 | -25.54 Mn |
| Sep 30, 2020 | -24.54 Mn |
| Mar 31, 2020 | -57.65 Mn |
| Dec 31, 2019 | -38.47 Mn |
| Sep 30, 2019 | -5.48 Mn |
| Jun 30, 2019 | -27.08 Mn |
| Mar 31, 2019 | -29.38 Mn |
| Dec 31, 2018 | -30.33 Mn |